Pacylex Pharmaceuticals, Inc.
Pacylex is developing a new, oral, first-in-class cancer treatment based on newly discovered driver biology in leukaemia, lymphoma and solid tumors.
- Stage Product In Development
- Industry Biotechnology
- Location Edmonton, AB, Canada
- Currency CAD
- Founded July 2012
- Employees 6
- Incorporation Type Other
- Website pacylex.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.